Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in Early Rheumatoid Arthritis with Low Disease Activity
NCT02123264Phase 3Terminated
- Start
- May 2014
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in rheumatoid arthritis (RA). Started May 2014; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02123264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123264.